Holdings of ProShares Ultra Nasdaq Biotechnology
ProShares Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 91.7M $ including 61.9M $ in equities, 67.5 %
- Positions
- 260 in 18 countries
- Top ten
- 31.5 % of net assets
- Filed on
- Feb 28, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 201 | Aquestive Therapeutics Inc | 5,633 | 22.5K $ | 0.02 % |
| 202 | Galapagos NV | 668 | 22.5K $ | 0.02 % |
| 203 | Solid Biosciences Inc | 3,598 | 22.3K $ | 0.02 % |
| 204 | Invivyd Inc | 12,796 | 21.6K $ | 0.02 % |
| 205 | Prothena Corp PLC | 2,485 | 21.5K $ | 0.02 % |
| 206 | SIGA Technologies Inc | 3,307 | 21.4K $ | 0.02 % |
| 207 | REGENXBIO Inc | 2,337 | 21.1K $ | 0.02 % |
| 208 | Entrada Therapeutics Inc | 1,765 | 21.1K $ | 0.02 % |
| 209 | Eton Pharmaceuticals Inc | 1,239 | 21.1K $ | 0.02 % |
| 210 | Larimar Therapeutics Inc | 3,953 | 21K $ | 0.02 % |
| 211 | Fulcrum Therapeutics Inc | 2,499 | 20.9K $ | 0.02 % |
| 212 | Altimmune Inc | 4,819 | 20.8K $ | 0.02 % |
| 213 | Tectonic Therapeutic Inc | 864 | 20.3K $ | 0.02 % |
| 214 | Keros Therapeutics Inc | 1,406 | 20K $ | 0.02 % |
| 215 | PepGen Inc | 3,175 | 19.7K $ | 0.02 % |
| 216 | LENZ Therapeutics Inc | 1,445 | 19.5K $ | 0.02 % |
| 217 | Upstream Bio Inc | 2,495 | 19.2K $ | 0.02 % |
| 218 | Enanta Pharmaceuticals Inc | 1,332 | 19K $ | 0.02 % |
| 219 | Absci Corp | 6,944 | 19K $ | 0.02 % |
| 220 | Anavex Life Sciences Corp | 4,125 | 18.3K $ | 0.02 % |
| 221 | Aura Biosciences Inc | 2,932 | 17.3K $ | 0.02 % |
| 222 | Atea Pharmaceuticals Inc | 3,607 | 16.9K $ | 0.02 % |
| 223 | Neurogene Inc | 715 | 16.8K $ | 0.02 % |
| 224 | Kyverna Therapeutics Inc | 2,023 | 16.6K $ | 0.02 % |
| 225 | Contineum Therapeutics Inc | 1,067 | 16.4K $ | 0.02 % |
| 226 | Autolus Therapeutics PLC | 9,262 | 15.8K $ | 0.02 % |
| 227 | NovaBridge Biosciences | 4,801 | 15.7K $ | 0.02 % |
| 228 | Immuneering Corp | 2,981 | 14.9K $ | 0.02 % |
| 229 | Foghorn Therapeutics Inc | 2,611 | 14.8K $ | 0.02 % |
| 230 | Cabaletta Bio Inc | 4,445 | 14.8K $ | 0.02 % |
| 231 | Aclaris Therapeutics Inc | 5,003 | 14.4K $ | 0.02 % |
| 232 | AC Immune SA | 4,636 | 13.6K $ | 0.01 % |
| 233 | Candel Therapeutics Inc | 2,535 | 13.3K $ | 0.01 % |
| 234 | Puma Biotechnology Inc | 2,326 | 13.3K $ | 0.01 % |
| 235 | Evolus Inc | 2,993 | 12.9K $ | 0.01 % |
| 236 | Aardvark Therapeutics Inc | 1,005 | 12.6K $ | 0.01 % |
| 237 | Lifecore Biomedical Inc | 1,730 | 12.5K $ | 0.01 % |
| 238 | Bicycle Therapeutics PLC | 2,136 | 12.2K $ | 0.01 % |
| 239 | C4 Therapeutics Inc | 4,475 | 12.1K $ | 0.01 % |
| 240 | Vor BioPharma Inc | 778 | 12K $ | 0.01 % |
| 241 | Silence Therapeutics PLC | 2,169 | 11.8K $ | 0.01 % |
| 242 | OmniAb Inc | 6,647 | 11.4K $ | 0.01 % |
| 243 | Orchestra BioMed Holdings Inc | 2,607 | 11.4K $ | 0.01 % |
| 244 | Voyager Therapeutics Inc | 2,721 | 11.2K $ | 0.01 % |
| 245 | Arcturus Therapeutics Holdings Inc | 1,312 | 10.8K $ | 0.01 % |
| 246 | Editas Medicine Inc | 4,508 | 9.9K $ | 0.01 % |
| 247 | Humacyte Inc | 8,647 | 9.6K $ | 0.01 % |
| 248 | Coherus Oncology Inc | 5,581 | 9.3K $ | 0.01 % |
| 249 | Quantum-Si Inc | 9,030 | 8.6K $ | 0.01 % |
| 250 | Caribou Biosciences Inc | 4,316 | 8.2K $ | 0.01 % |
| 251 | Sagimet Biosciences Inc | 1,432 | 8.2K $ | 0.01 % |
| 252 | Jyong Biotech Ltd. | 3,511 | 7.5K $ | 0.01 % |
| 253 | Black Diamond Therapeutics Inc | 2,631 | 6.5K $ | 0.01 % |
| 254 | Alpha Teknova Inc | 2,471 | 6.4K $ | 0.01 % |
| 255 | Rani Therapeutics Holdings Inc | 4,504 | 6.2K $ | 0.01 % |
| 256 | Gossamer Bio Inc | 10,687 | 4.5K $ | 0.01 % |
| 257 | Tenaya Therapeutics Inc | 7,688 | 4.3K $ | 0.00 % |
| 258 | Pyxis Oncology Inc | 2,875 | 4.2K $ | 0.00 % |
| 259 | Codexis Inc | 4,171 | 4.2K $ | 0.00 % |
| 260 | Sutro Biopharma Inc | 1 | 20.5 $ |
Sector breakdown
- Health care 52.9 %
- Unattributed 47.1 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 89.4 %
- Netherlands 2.2 %
- Bermuda 1.5 %
- France 1.5 %
- Ireland 1.3 %
- Denmark 1.2 %
- Germany 0.8 %
- Canada 0.6 %
- Switzerland 0.4 %
- Cayman Islands 0.3 %
- Singapore 0.2 %
- Jersey 0.1 %
- Other countries 0.4 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 224 | 55.3M $ | 89.45 % |
| 2 | Netherlands | 4 | 1.3M $ | 2.17 % |
| 3 | Bermuda | 1 | 929.4K $ | 1.50 % |
| 4 | France | 2 | 925.2K $ | 1.50 % |
| 5 | Ireland | 4 | 826.8K $ | 1.34 % |
| 6 | Denmark | 2 | 741.4K $ | 1.20 % |
| 7 | Germany | 1 | 514.7K $ | 0.83 % |
| 8 | Canada | 4 | 369.8K $ | 0.60 % |
| 9 | Switzerland | 2 | 278.2K $ | 0.45 % |
| 10 | Cayman Islands | 5 | 160K $ | 0.26 % |
| 11 | Singapore | 1 | 107.6K $ | 0.17 % |
| 12 | Jersey | 1 | 70.7K $ | 0.11 % |
Cite this page
Titelia. "Holdings of ProShares Ultra Nasdaq Biotechnology". https://titelia.com/en/funds/S000018718